TrialDiabetes, obesity & metabolism2022

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

Taha Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.